CalciMedica annual return on equity
2021
2024
2025
CalciMedica Return on Equity (ROE) Growth & History (CALC)
CalciMedica's return on equity was −761.02% for fiscal 2025.
View full CalciMedica company overviewCalciMedica annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −761.02% | −639.61 pp |
| 2024 | 2024-12-31 | −121.42% | — |
| 2021 | 2021-12-31 | −232.61% | — |
CalciMedica quarterly return on equity
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −347.11% | −277.00 pp |
| Q3 2025 | 2025-09-30 | −267.49% | −218.36 pp |
| Q2 2025 | 2025-06-30 | −70.11% | −44.67 pp |
| Q1 2025 | 2025-03-31 | −39.86% | −40.88 pp |
| Q4 2024 | 2024-12-31 | −36.33% | +4.48 pp |
| Q3 2024 | 2024-09-30 | −49.13% | −16.58 pp |
| Q2 2024 | 2024-06-30 | −25.44% | +7.53 pp |
| Q1 2024 | 2024-03-31 | 1.02% | — |
| Q4 2023 | 2023-12-31 | −40.82% | — |
| Q3 2023 | 2023-09-30 | −32.55% | — |
| Q2 2023 | 2023-06-30 | −32.97% | — |
| Q4 2021 | 2021-12-31 | −212.91% | −203.04 pp |
| Q3 2021 | 2021-09-30 | −10.60% | — |
| Q2 2021 | 2021-06-30 | −9.44% | — |
| Q1 2021 | 2021-03-31 | −12.77% | — |
| Q4 2020 | 2020-12-31 | −9.87% | — |
CalciMedica return on equity trends
Between the periods ended 2021-12-31 and 2025-12-31, CalciMedica's return on equity decreased from −232.61% to −761.02%, a change of −528.41 percentage points. The latest reported quarter, Q2 2026, shows −347.11%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review CalciMedica source filings ↗